| Primary |
| Foetal Exposure During Pregnancy |
12.5% |
| Colon Cancer |
10.0% |
| Product Used For Unknown Indication |
10.0% |
| Urinary Tract Infection |
10.0% |
| Antibiotic Prophylaxis |
7.5% |
| Anaesthesia |
5.0% |
| Deep Vein Thrombosis |
5.0% |
| Gastrooesophageal Reflux Disease |
5.0% |
| Hypertension |
5.0% |
| Infection |
5.0% |
| Pain |
5.0% |
| Depression |
2.5% |
| Diverticulitis |
2.5% |
| Headache |
2.5% |
| Nausea |
2.5% |
| Sepsis Neonatal |
2.5% |
| Sleep Disorder |
2.5% |
| Systemic Antibacterial Therapy |
2.5% |
| Tonsillitis |
2.5% |
|
| Medication Error |
18.2% |
| Congenital Oral Malformation |
9.1% |
| Bleeding Time Prolonged |
4.5% |
| Clostridium Difficile Colitis |
4.5% |
| Congenital Cardiovascular Anomaly |
4.5% |
| Deep Vein Thrombosis |
4.5% |
| Drug Administration Error |
4.5% |
| Drug Hypersensitivity |
4.5% |
| Ear Malformation |
4.5% |
| Foetal Exposure During Pregnancy |
4.5% |
| Paresis |
4.5% |
| Premature Labour |
4.5% |
| Pyrexia |
4.5% |
| Rash |
4.5% |
| Respiratory Distress |
4.5% |
| Systemic Lupus Erythematosus |
4.5% |
| Vasculitis |
4.5% |
| Wheezing |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
27.7% |
| Bacteraemia |
13.6% |
| Hypertension |
7.6% |
| Diarrhoea |
6.1% |
| Drug Exposure During Pregnancy |
6.1% |
| Pyrexia |
6.1% |
| Type 2 Diabetes Mellitus |
5.3% |
| Depression |
3.4% |
| Behcet's Syndrome |
2.7% |
| Antibiotic Therapy |
2.3% |
| Maternal Exposure During Pregnancy |
2.3% |
| Pneumonia |
2.3% |
| Toxic Epidermal Necrolysis |
2.3% |
| Bronchitis Chronic |
1.9% |
| Hyperlipidaemia |
1.9% |
| Infection Prophylaxis |
1.9% |
| Myocardial Ischaemia |
1.9% |
| Skin Test Positive |
1.9% |
| Drug Use For Unknown Indication |
1.5% |
| Endocarditis Prophylaxis |
1.5% |
|
| Septic Shock |
13.3% |
| Toxic Epidermal Necrolysis |
13.3% |
| Candida Sepsis |
11.1% |
| Arthralgia |
6.7% |
| Drug Hypersensitivity |
6.7% |
| Weight Decreased |
6.7% |
| Colitis |
4.4% |
| Diarrhoea |
4.4% |
| Disseminated Intravascular Coagulation |
4.4% |
| Medication Error |
4.4% |
| Pseudomembranous Colitis |
4.4% |
| Acute Generalised Exanthematous Pustulosis |
2.2% |
| Apgar Score Low |
2.2% |
| Blood Magnesium Decreased |
2.2% |
| Bradycardia |
2.2% |
| Dermatitis Allergic |
2.2% |
| Hypoglycaemia |
2.2% |
| Liver Disorder |
2.2% |
| Lung Infiltration |
2.2% |
| Maternal Drugs Affecting Foetus |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.2% |
| Prophylaxis |
7.9% |
| Multiple Myeloma |
4.7% |
| Hypertension |
4.5% |
| Depression |
3.5% |
| Infection Prophylaxis |
3.3% |
| Nausea |
3.1% |
| Acne |
2.9% |
| Pain |
2.9% |
| Acute Lymphocytic Leukaemia |
2.7% |
| Dermatitis |
1.8% |
| Diabetic Neuropathy |
1.8% |
| Pneumonia |
1.8% |
| Catheterisation Cardiac |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Contraception |
1.6% |
| Foetal Exposure During Pregnancy |
1.6% |
| Urinary Tract Infection |
1.5% |
| Arthritis |
1.4% |
| Hiv Infection |
1.4% |
|
| Vomiting |
13.7% |
| Weight Increased |
12.7% |
| Pyrexia |
5.9% |
| Viral Pharyngitis |
5.9% |
| Wheezing |
5.9% |
| Anxiety |
4.9% |
| Pulmonary Haemorrhage |
4.9% |
| White Blood Cell Count Abnormal |
4.9% |
| Drug Ineffective |
3.9% |
| Pain |
3.9% |
| Stillbirth |
3.9% |
| Suicidal Ideation |
3.9% |
| Vertigo |
3.9% |
| Weight Decreased |
3.9% |
| Diarrhoea |
2.9% |
| Injury |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Off Label Use |
2.9% |
| Osteopenia |
2.9% |
| Renal Failure Acute |
2.9% |
|
| Interacting |
|
| Urinary Tract Infection |
66.7% |
| Drug Interaction |
33.3% |
|
